Get startedLog in
    Picture of BoneSupport Holding AB logo

    BONEX — BoneSupport Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Brief: Bonesupport Holding Upwardly Revises U.S. Market Opportunity

    Picture of BoneSupport Holding AB logoBoneSupport Holding AB
    26/05/2026 06:34
    May 26 (Reuters) - Bonesupport Holding AB BONEX.ST:

HOSTS ITS CAPITAL MARKETS DAY

UPWARD REVISION OF U.S. MARKET OPPORTUNITY TO ABOUT 460,000 PROCEDURES (FROM 380,000)

PROGRESSION IN SPINE WITH MULTICENTRE STUDY, PLANNED TO START IN 2027

TARGETED FDA SUBMISSION NO LATER THAN 2031

Source text: ID:nMFNbZ12dZ

Further company coverage: BONEX.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on BoneSupport Holding AB

    See all news